Safety and Efficacy of GENOSS® DCB With a Shellac Plus Vitamin E Excipient in Patients With De Novo Lesion

Clinical trial NCT07158307 · ENROLLING_BY_INVITATION

Trial details

NCT number: NCT07158307
Sponsor: Genoss Co., Ltd.
Status: ENROLLING_BY_INVITATION
Study type: OBSERVATIONAL

Coronary Artery Disease(CAD)

Start date: 2024-06-27
Primary completion: 2030-06-27
Enrollment: 3000

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.